| T8373 |
6-Diazo-5-oxo-L-nor-Leucine
|
157-03-9
|
98%
|
|
|
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) is an antagonist of glutaminases (Ki : 6 μM). It is an antineoplastic antibiotic produced by an unidentif...
|
| T3968 |
GK921
|
1025015-40-0
|
|
|
|
GK921 is a transglutaminase 2 (TGase) inhibitor.
|
| T20121 |
L-Albizziin
|
1483-07-4
|
100%
|
|
|
L-Albizziin (L-beta-Ureidoalanine) is a glutamase inhibitor and is a glutaminyl-tRNA synthetase inhibitor.
|
| T17206 |
UPGL00004
|
1890169-95-5
|
97.44%
|
|
|
UPGL00004 is a potent glutaminase C (GAC) inhibitor with an IC50 of 29 nM. Kd of UPGL00004 for GAC was 27 nM. UPGL00004 has a strong inhibitory effect on the pro...
|
| T62560 |
Sirpiglenastat
|
2079939-05-0
|
98.01%
|
|
|
Sirpiglenastat (DRP-104) is a glutamine antagonist, a prodrug of DON, with antitumor activity that acts by inhibiting glutamine metabolism and stimulating the in...
|
| T6791 |
BPTES
|
314045-39-1
|
98.06%
|
|
|
BPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.
|
| T67865 |
BJJF078
|
2531244-56-9
|
98.19%
|
|
|
BJJF078, an aminopiperidine derivative, is a potent inhibitor of recombinant human and mouse glutamine aminotransferase (TG2) activity, with IC50 values of 41 an...
|
| T37385 |
Glutaminase-IN-3
|
1439399-45-7
|
98.51%
|
|
|
Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.
|
| T17289 |
ZED-1227
|
1542132-88-6
|
99.04%
|
|
|
ZED-1227 (TAK-227) is an orally active, selective and potent transglutaminase 2 (TG2) inhibitor with anticancer activity that blocks inflammation-induced TG2 exp...
|
| T3964 |
Glutaminase C-IN-1
|
311795-38-7
|
99.82%
|
|
|
Glutaminase C-IN-1 (Compound 968) is a Glutaminase C allosteric inhibitor.
|
| T6797 |
Telaglenastat
|
1439399-58-2
|
99.89%
|
|
|
Telaglenastat (CB 839) (IC50 of 24 nM), an effective, specific, and oral inhibitor, which is bioavailable glutaminase, for recombinant human GAC.
|
| T72679 |
GLS1 Inhibitor-4
|
2768599-97-7
|
98%
|
|
|
GLS1 Inhibitor-4 (compound 41e) is a powerful GLS1 inhibitor, demonstrating an IC50 of 11.86 nM. It exhibits antiproliferative effects, substantial metabolic sta...
|
| T79340 |
GLS1 Inhibitor-7
|
|
98%
|
|
|
GLS1 Inhibitor-7 (compound 4d) serves as a GLS1 antagonist with an IC50 value of 46.7 μM, demonstrating potential applications in anticancer, antiaging, and anti...
|
| T78892 |
Glutaminase C-IN-2
|
|
98%
|
|
|
Glutaminase C-IN-2 (compound 11), an allosteric inhibitor of glutaminase C (GAC), exhibits potent inhibitory activity with an IC50 of 10.64 nM. By disrupting glu...
|
